Cervical Interbody Fusion Device Patient Registry

Restor3D73 enrolled

Overview

The registry has been designed as a prospective, observational program for patients undergoing anterior cervical discectomy and fusion (ACDF) procedures treated with TIDAL cervical interbody fusion device. The ultimate goal of the study is to aid in the development of treatment pathways and improved patient care. All patients who agree to participate in the registry will sign an informed consent form and subsequently be treated by their surgeon with the device in either an inpatient or outpatient facility.

The registry is design to collect data prospectively on patients undergoing spinal fusion using the TIDAL cervical interbody fusion device. Patients will be enrolled in the registry after reviewing the protocol with their health care provider and signing the informed consent. Data will be collected at recommended time points based on the standards of care of the participating sites. The registry will serve as a database in which retrospective analysis and exploratory analysis of specific research questions will be answered. Follow up visits will be defined by the treating physicians based on their standard practice. Typical clinical follow up schedules for patients undergoing this type of surgery are pre-operative and 12 months post-operative.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Degenerative Disc Disease

Interventions

TIDAL Cervical Interbody Fusion implantDEVICE

Cervical interbody fusion device

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Neck and arm pain for a minimum of 6 weeks before surgery that is recalcitrant to nonoperative treatment modalities, such as physical therapy, reduced activities, and anti-inflammatory medications. * Radiographic evidence of cervical disc disease that is documented on dynamic radiographs and magnetic resonance imaging (MRI). Exclusion Criteria: * Medical condition that required medication, such as steroids or nonsteroidal anti-inflammatory medications, that could interfere with fusion. There are no restrictions on sex or ethnicity.

Locations (1)

Orthopaedic Institute of Western Kentucky

Paducah, Kentucky, United States

Outcomes

Primary Outcomes

Change in Oswestry Disability Index (ODI)/Neck Disability Index (NDI) Score Range 0-50 at 1 year post-operative from a pre-operative baseline

ODI/NDI Score Range: 0-50 0-4 No disability 5-14 Mild disability 15-24 Moderate disability 25-34 Severe disability \>34 Complete disability

Time frame: 1 year

Change in VAS Pain at 1 year post-operative from a pre-operative baseline

VAS PAIN SEVERITY SCALE ranges from 0-10. A score of zero (0) means 'no pain' and a ten (10) means 'worst imaginable pain'

Time frame: 1 year

Secondary Outcomes

Improvement in patient reported short-form 36 (SF36) scores at 1 year post-operative from a pre-operative baseline

Questionnaire of generic, coherent, and easily administered quality-of-life measures.

Time frame: 1 year

Rate of Successful Fusion Based on Radiological Assessment at 1 Year Post-op

Assessment of fusion

Time frame: 1 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.